GPT and Hyperbilirubinemia: Among all ADRs, non-hematologic toxicities were predominant, with the most common being hyperbilirubinemia (28.1%), elevated ALT (26.4%), and hypercholesterolemia (24.0%), primarily grade 1–2 (27.3%, 25.6%, and 24.0%, respectively).